168 related articles for article (PubMed ID: 16110059)
1. US drug industry's guidelines on advertising too limited, say critics.
Burton B
BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059
[No Abstract] [Full Text] [Related]
2. New DTC guidelines please drug companies, anger critics.
Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
[No Abstract] [Full Text] [Related]
3. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
Kellerman R;
Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
[No Abstract] [Full Text] [Related]
4. Drug industry's new code criticised for lacking teeth.
Coombes R
BMJ; 2005 Nov; 331(7527):1225. PubMed ID: 16308367
[No Abstract] [Full Text] [Related]
5. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
6. Can drug companies have it both ways?
Rapp MS
CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
[No Abstract] [Full Text] [Related]
7. Student rally. Med school attendees write ethics code on drug firms.
Romano M
Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
[No Abstract] [Full Text] [Related]
8. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
9. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
Hayes TA
Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
[No Abstract] [Full Text] [Related]
10. Drug firms back-pedal on direct advertising.
Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
[No Abstract] [Full Text] [Related]
11. Capitol Hill panelists want FDA intervention in DTC drug advertising.
Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177
[No Abstract] [Full Text] [Related]
12. Drug firms vow to tone down consumer advertisements.
Wadman M
Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
[No Abstract] [Full Text] [Related]
13. Practice advisory: participation of neurologists in direct-to-consumer advertising.
Ethics, Law and Humanities Committee of the American Academy of Neurology
Neurology; 2001 Apr; 56(8):995-6. PubMed ID: 11320169
[No Abstract] [Full Text] [Related]
14. Complaints about advertising of medicines are encouraged.
Simmonds H
BMJ; 2002 Apr; 324(7341):850-1. PubMed ID: 11934787
[No Abstract] [Full Text] [Related]
15. Drug marketing practices criticized.
Wagner L
Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
[No Abstract] [Full Text] [Related]
16. Lundbeck broke advertising rules.
Dyer O
BMJ; 2003 May; 326(7397):1004. PubMed ID: 12742919
[No Abstract] [Full Text] [Related]
17. Inconsistency in DTCA practices by manufacturers: is it time to standardize print summaries?
Sansgiry SS; Kawatkar AA
Value Health; 2004; 7(2):216-7. PubMed ID: 15164811
[No Abstract] [Full Text] [Related]
18. Direct-to-consumer advertising: education or anathema?
Rosner F; Kark P; Packer S; Bennett A; Berger J
JAMA; 1999 Oct; 282(13):1227; author reply 1227-8. PubMed ID: 10517421
[No Abstract] [Full Text] [Related]
19. Adderall and the FDA.
Diller LH
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):737. PubMed ID: 11437005
[No Abstract] [Full Text] [Related]
20. Drug advertising.
Moulds RF; Wing LM
Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
